Approval · Notice of Compliance 15811 · 2014
APOQUEL: Notice of Compliance 15811
Issued July 15, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15811
- Date
- July 15, 2014
- Company
- Zoetis Canada IncKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Janus kinase inhibitor
Products in this notice
Medicinal ingredients
- OCLACITINIB MALEATE 3.6 MG per TAB
- OCLACITINIB MALEATE 5.4 MG per TAB
- OCLACITINIB MALEATE 16 MG per TAB